Impact of High-Risk Human Papillomavirus Testing on Pap Test Screening Complexity

被引：0
|
作者：
Torous, Vanda [1 ]
Brancely, Dawn [1 ]
Carpio, Luis [1 ]
VanderLaan, Paul [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
469
引用
收藏
页码：121A / 121A
页数：1
相关论文
共 50 条
  • [1] Impact of High-Risk Human Papillomavirus Testing on Pap Test Screening Complexity
    Torous, Vanda
    Brancely, Dawn
    Carpio, Luis
    VanderLaan, Paul
    MODERN PATHOLOGY, 2017, 30 : 121A - 121A
  • [2] Risk Factors Triage on High-Risk Human Papillomavirus Testing Screening
    Ye, Jing
    Fei, Huali
    Ye, Feng
    Lue, Weiguo
    Xie, Xing
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (08) : 1374 - 1380
  • [3] High-risk Human Papillomavirus Testing for Cervical Cancer Screening
    Totten, Stephanie P. S.
    Romero, Joan Miguel
    JAMA ONCOLOGY, 2021, 7 (07) : 1066 - 1067
  • [4] High-risk Human Papillomavirus in a screening population
    Schledermann, D. E.
    Rasmussen, M.
    Mose, L.
    APMIS, 2011, 119 : 18 - 19
  • [5] The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings
    Cardenas-Turanzas, Marylou
    Nogueras-Gonzalez, Graciela M.
    Scheurer, Michael E.
    Adler-Storthz, Karen
    Benedet, J. L.
    Beck, J. Robert
    Follen, Michele
    Cantor, Scott B.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2865 - 2871
  • [6] High-risk Human Papillomavirus Testing for Cervical Cancer Screening-Reply
    Dang, Le
    Qiao, Youlin
    Lang, Jinghe
    JAMA ONCOLOGY, 2021, 7 (07) : 1067 - 1068
  • [7] Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
    Stuebs, Frederik A.
    Koch, Martin C.
    Dietl, Anna K.
    Adler, Werner
    Geppert, Carol
    Hartmann, Arndt
    Knoell, Antje
    Beckmann, Matthias W.
    Mehlhorn, Grit
    Schulmeyer, Carla E.
    Gass, Paul
    DIAGNOSTICS, 2022, 12 (07)
  • [8] High-risk human papillomavirus test a good option for cervical cancer screening
    Printz, Carrie
    CANCER, 2018, 124 (24) : 4591 - 4591
  • [9] Urine high-risk human papillomavirus testing - an alternative to routine cervical screening strategy
    Davies-Oliveira, Jennifer C.
    Sargent, Alexandra
    Pinggera, Elisabeth
    Carter, Suzanne
    Gilham, Clare
    Crosbie, Emma J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 37 - 37
  • [10] Comparison of the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay for detection of high-risk human papillomavirus in women with abnormal PAP smear
    De Francesco, M. A.
    Gargiulo, E.
    Schreiber, C.
    Ciravolo, G.
    Salinaro, E.
    Manca, N.
    JOURNAL OF VIROLOGICAL METHODS, 2008, 147 (01) : 10 - 17
12345